Cited by 47Bone Metabolism and DiseasesImmune Response and InflammationBone health and osteoporosis research

Toll-like receptor 9 deficiency induces osteoclastic bone loss via gut microbiota-associated systemic chronic inflammation

Open access
Ding, Peng, Tan, Qiyuan, Wei, Zhanying, Chen, Qiyu, Wang, Chun, Qi, Luyue, Wen, Li, Zhang, Changqing +1 more·2022·Bone Research

Abstract

Toll-like receptors (TLRs) play pivotal roles in inflammation and provide important links between the immune and skeletal systems. Although the activation of TLRs may affect osteoclast differentiation and bone metabolism, whether and how TLRs are required for normal bone remodeling remains to be fully explored. In the current study, we show for the first time that TLR9−/−mice exhibit a low bone mass and low-grade systemic chronic inflammation, which is characterized by the expansion of CD4+T cells and increased levels of inflammatory cytokines, including TNF α, RANKL, and IL1 β. The increased levels of these cytokines significantly promote osteoclastogenesis and induce bone loss. Importantly, TLR9 deletion alters the gut microbiota, and this dysbiosis is the basis of the systemic inflammation and bone loss observed in TLR9−/−mice. Furthermore, through single-cell RNA sequencing, we identified myeloid-biased hematopoiesis in the bone marrow of TLR9−/−mice and determined that the increase in myelopoiesis, likely caused by the adaptation of hematopoietic stem cells to systemic inflammation, also contributes to inflammation-induced osteoclastogenesis and subsequent bone loss in TLR9−/−mice. Thus, our study provides novel evidence that TLR9 signaling connects the gut microbiota, immune system, and bone and is critical in maintaining the homeostasis of inflammation, hematopoiesis, and bone metabolism under normal conditions.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41413-022-00210-3

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 83

  1. [1]Tsukasaki M Takayanagi H Osteoimmunology: evolving concepts in bone-immune interactions in health and disease Nat. Rev. Immunol. 2019 19 626 642 10.1038/s41577-019-0178-8 31186549 · DOI
  2. [2]Terashima A Sepsis-induced osteoblast ablation causes immunodeficiency Immunity 2016 44 1434 1443 10.1016/j.immuni.2016.05.012 27317262 · DOI
  3. [3]Madel MB Immune function and diversity of osteoclasts in normal and pathological conditions Front. Immunol. 2019 10 1408 10.3389/fimmu.2019.01408 31275328 PMC6594198 · DOI
  4. [4]Li Y B cells and T cells are critical for the preservation of bone homeostasis and attainment of peak bone mass in vivo Blood 2007 109 3839 3848 10.1182/blood-2006-07-037994 17202317 PMC1874582 · DOI · Paper page
  5. [5]Weitzmann MN Ofotokun I Physiological and pathophysiological bone turnover - role of the immune system Nat. Rev. Endocrinol. 2016 12 518 532 10.1038/nrendo.2016.91 27312863 PMC5857945 · DOI
  6. [6]van Bodegraven AA Bravenboer N Perspective on skeletal health in inflammatory bowel disease Osteoporos. Int. 2020 31 637 646 10.1007/s00198-019-05234-w 31822927 PMC7075921 · DOI
  7. [7]Yu M PTH induces bone loss via microbial-dependent expansion of intestinal TNF+ T cells and Th17 cells Nat. Commun 2020 11 468 10.1038/s41467-019-14148-4 31980603 PMC6981196 · DOI · Paper page
  8. [8]Farr JN Targeting cellular senescence prevents age-related bone loss in mice Nat. Med. 2017 23 1072 1079 10.1038/nm.4385 28825716 PMC5657592 · DOI · Paper page
  9. [9]D’Amelio P Estrogen deficiency increases osteoclastogenesis up-regulating T cells activity: a key mechanism in osteoporosis Bone 2008 43 92 100 10.1016/j.bone.2008.02.017 18407820 · DOI · Paper page
  10. [10]Li JY Sex steroid deficiency-associated bone loss is microbiota dependent and prevented by probiotics J. Clin. Investig. 2016 126 2049 2063 10.1172/JCI86062 27111232 PMC4887186 · DOI · Paper page
  11. [11]Iqbal J Yuen T Sun L Zaidi M From the gut to the strut: where inflammation reigns, bone abstains J. Clin. Investig. 2016 126 2045 2048 10.1172/JCI87430 27111233 PMC4887160 · DOI
  12. [12]Kawasaki T Kawai T Toll-like receptor signaling pathways Front. Immunol. 2014 5 461 10.3389/fimmu.2014.00461 25309543 PMC4174766 · DOI
  13. [13]Hemmi H A Toll-like receptor recognizes bacterial DNA Nature 2000 408 740 745 10.1038/35047123 11130078 · DOI · Paper page
  14. [14]Krug A TLR9-dependent recognition of MCMV by IPC and DC generates coordinated cytokine responses that activate antiviral NK cell function Immunity 2004 21 107 119 10.1016/j.immuni.2004.06.007 15345224 · DOI
  15. [15]Guiducci C Autoimmune skin inflammation is dependent on plasmacytoid dendritic cell activation by nucleic acids via TLR7 and TLR9 J. Exp. Med. 2010 207 2931 2942 10.1084/jem.20101048 21115693 PMC3005224 · DOI
  16. [16]Kim PD Toll-like receptor 9-mediated inflammation triggers alveolar bone loss in experimental murine periodontitis Infect. Immun. 2015 83 2992 3002 10.1128/IAI.00424-15 25964477 PMC4468549 · DOI
  17. [17]Bakker PJ TLR9 mediates remote liver injury following severe renal ischemia reperfusion PLoS One 2015 10 e0137511 10.1371/journal.pone.0137511 26361210 PMC4567139 · DOI
  18. [18]Ehlers M Fukuyama H McGaha TL Aderem A Ravetch JV TLR9/MyD88 signaling is required for class switching to pathogenic IgG2a and 2b autoantibodies in SLE J. Exp. Med. 2006 203 553 561 10.1084/jem.20052438 16492804 PMC2118244 · DOI
  19. [19]Fischer A The involvement of Toll-like receptor 9 in the pathogenesis of erosive autoimmune arthritis J. Cell. Mol. Med. 2018 22 4399 4409 10.1111/jcmm.13735 29992753 PMC6111819 · DOI
  20. [20]Ito T Toll-like receptor 9 activation is a key mechanism for the maintenance of chronic lung inflammation Am. J. Respir Crit. Care Med. 2009 180 1227 1238 10.1164/rccm.200906-0892OC 19797157 PMC2796734 · DOI
  21. [21]Summers SA TLR9 and TLR4 are required for the development of autoimmunity and lupus nephritis in pristane nephropathy J. Autoimmun. 2010 35 291 298 10.1016/j.jaut.2010.05.004 20810248 · DOI
  22. [22]Stanbery AG Newman ZR Barton GM Dysregulation of TLR9 in neonates leads to fatal inflammatory disease driven by IFN-gamma Proc. Natl. Acad. Sci. USA 2020 117 3074 3082 10.1073/pnas.1911579117 31980536 PMC7022150 · DOI
  23. [23]Bossaller L TLR9 deficiency leads to accelerated renal disease and myeloid lineage abnormalities in pristane-induced murine lupus J. Immunol. 2016 197 1044 1053 10.4049/jimmunol.1501943 27354219 PMC5266544 · DOI
  24. [24]Christensen SR Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus Immunity 2006 25 417 428 10.1016/j.immuni.2006.07.013 16973389 · DOI · Paper page
  25. [25]Han SJ Kim M Novitsky E D'Agati V Lee HT Intestinal TLR9 deficiency exacerbates hepatic IR injury via altered intestinal inflammation and short-chain fatty acid synthesis FASEB J 2020 34 12083 12099 10.1096/fj.202000314R 32738096 · DOI
  26. [26]Hong CP TLR9 regulates adipose tissue inflammation and obesity-related metabolic disorders Obesity 2015 23 2199 2206 10.1002/oby.21215 26260403 · DOI
  27. [27]Liu Y Seto NL Carmona-Rivera C Kaplan MJ Accelerated model of lupus autoimmunity and vasculopathy driven by toll-like receptor 7/9 imbalance Lupus Sci. Med. 2018 5 e000259 10.1136/lupus-2018-000259 29765617 PMC5950641 · DOI
  28. [28]Mande P Fas ligand promotes an inducible TLR-dependent model of cutaneous lupus-like inflammation J. Clin. Investig. 2018 128 2966 2978 10.1172/JCI98219 29889098 PMC6025993 · DOI
  29. [29]Bar-Shavit Z Taking a toll on the bones: regulation of bone metabolism by innate immune regulators Autoimmunity 2008 41 195 203 10.1080/08916930701694469 18365832 · DOI
  30. [30]Liu J Molecular mechanism of the bifunctional role of lipopolysaccharide in osteoclastogenesis J. Biol. Chem. 2009 284 12512 12523 10.1074/jbc.M809789200 19258321 PMC2673317 · DOI
  31. [31]Hou L Sasaki H Stashenko P Toll-like receptor 4-deficient mice have reduced bone destruction following mixed anaerobic infection Infect. Immun. 2000 68 4681 4687 10.1128/IAI.68.8.4681-4687.2000 10899873 PMC98410 · DOI
  32. [32]Takami M Kim N Rho J Choi Y Stimulation by toll-like receptors inhibits osteoclast differentiation J. Immunol. 2002 169 1516 1523 10.4049/jimmunol.169.3.1516 12133979 · DOI
  33. [33]Zou W Schwartz H Endres S Hartmann G Bar-Shavit Z CpG oligonucleotides: novel regulators of osteoclast differentiation FASEB J. 2002 16 274 282 10.1096/fj.01-0586com 11874977 · DOI
  34. [34]Amcheslavsky A Bar-Shavit Z Toll-like receptor 9 ligand blocks osteoclast differentiation through induction of phosphatase J. Bone Miner. Res. 2007 22 1301 1310 10.1359/jbmr.070501 17488193 · DOI
  35. [35]Amcheslavsky A Hemmi H Akira S Bar-Shavit Z Differential contribution of osteoclast- and osteoblast-lineage cells to CpG-oligodeoxynucleotide (CpG-ODN) modulation of osteoclastogenesis J. Bone Miner. Res. 2005 20 1692 1699 10.1359/JBMR.050515 16059640 · DOI
  36. [36]Tai N Wong FS Wen L TLR9 deficiency promotes CD73 expression in T cells and diabetes protection in nonobese diabetic mice J. Immunol. 2013 191 2926 2937 10.4049/jimmunol.1300547 23956420 PMC3788667 · DOI
  37. [37]Liu M Toll-like receptor 9 negatively regulates pancreatic islet beta cell growth and function in a mouse model of type 1 diabetes Diabetologia 2018 61 2333 2343 10.1007/s00125-018-4705-0 30094467 PMC6182661 · DOI
  38. [38]Horowitz MC Fretz JA Lorenzo JA How B cells influence bone biology in health and disease Bone 2010 47 472 479 10.1016/j.bone.2010.06.011 20601290 PMC2941392 · DOI
  39. [39]Netea MG A guiding map for inflammation Nat. Immunol. 2017 18 826 831 10.1038/ni.3790 28722720 PMC5939996 · DOI · Paper page
  40. [40]Kawai VK Stein CM Perrien DS Griffin MR Effects of anti-tumor necrosis factor alpha agents on bone Curr. Opin. Rheumatol. 2012 24 576 585 10.1097/BOR.0b013e328356d212 22810364 PMC3753172 · DOI
  41. [41]Vijay-Kumar M Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5 Science 2010 328 228 231 10.1126/science.1179721 20203013 PMC4714868 · DOI · Paper page
  42. [43]Yu M Ovariectomy induces bone loss via microbial-dependent trafficking of intestinal TNF+ T cells and Th17cells J Clin. Investig 2021 131 e143137 10.1172/JCI143137 PMC7880410 33586672 · DOI
  43. [45]Lopetuso LR Gut microbiota in health, diverticular disease, irritable bowel syndrome, and inflammatory bowel diseases: time for microbial marker of gastrointestinal disorders Dig. Dis. 2018 36 56 65 10.1159/000477205 28683448 · DOI
  44. [46]He C MicroRNA 301A promotes intestinal inflammation and colitis-associated cancer development by inhibiting BTG1 Gastroenterology 2017 152 1434 1448 e1415 10.1053/j.gastro.2017.01.049 28193514 · DOI
  45. [47]Caruso R Ono M Bunker ME Nunez G Inohara N Dynamic and asymmetric changes of the microbial communities after cohousing in laboratory mice Cell Rep. 2019 27 3401 3412 e3403 10.1016/j.celrep.2019.05.042 31189120 PMC6690056 · DOI
  46. [48]Chavakis T Mitroulis I Hajishengallis G Hematopoietic progenitor cells as integrative hubs for adaptation to and fine-tuning of inflammation Nat. Immunol. 2019 20 802 811 10.1038/s41590-019-0402-5 31213716 PMC6709414 · DOI
  47. [49]Schultze JL Mass E Schlitzer A Emerging principles in myelopoiesis at homeostasis and during infection and inflammation Immunity 2019 50 288 301 10.1016/j.immuni.2019.01.019 30784577 · DOI
  48. [51]Paul F Transcriptional heterogeneity and lineage commitment in myeloid progenitors Cell 2015 163 1663 1677 10.1016/j.cell.2015.11.013 26627738 · DOI · Paper page
  49. [52]Lord KA Abdollahi A Hoffman-Liebermann B Liebermann DA Proto-oncogenes of the fos/jun family of transcription factors are positive regulators of myeloid differentiation Mol. Cell. Biol. 1993 13 841 851 8423806 PMC358967
  50. [53]Velten L Human haematopoietic stem cell lineage commitment is a continuous process Nat. Cell Biol. 2017 19 271 281 10.1038/ncb3493 28319093 PMC5496982 · DOI · Paper page
  51. [54]Mallampati S Integrated genetic approaches identify the molecular mechanisms of Sox4 in early B-cell development: intricate roles for RAG1/2 and CK1epsilon Blood 2014 123 4064 4076 10.1182/blood-2013-12-543801 24786772 PMC4073324 · DOI
  52. [55]Oltz EM A novel regulatory myosin light chain gene distinguishes pre-B cell subsets and is IL-7 inducible EMBO J. 1992 11 2759 2767 10.1002/j.1460-2075.1992.tb05341.x 1628631 PMC556751 · DOI
  53. [56]Maitra U Gan L Chang S Li L Low-dose endotoxin induces inflammation by selectively removing nuclear receptors and activating CCAAT/enhancer-binding protein delta J. Immunol. 2011 186 4467 4473 10.4049/jimmunol.1003300 21357541 · DOI
  54. [57]Balamurugan K FBXW7alpha attenuates inflammatory signalling by downregulating C/EBPdelta and its target gene Tlr4 Nat. Commun. 2013 4 1662 10.1038/ncomms2677 23575666 PMC3625980 · DOI
  55. [58]Caiado F Pietras EM Manz MG Inflammation as a regulator of hematopoietic stem cell function in disease, aging, and clonal selection J Exp. Med 2021 218 e20201541 10.1084/jem.20201541 34129016 PMC8210622 · DOI · Paper page
  56. [59]Lee S Bone marrow CX3CR1+ mononuclear cells relay a systemic microbiota signal to control hematopoietic progenitors in mice Blood 2019 134 1312 1322 10.1182/blood.2019000495 31387916 PMC6888141 · DOI
  57. [60]Friedman AD Transcriptional control of granulocyte and monocyte development Oncogene 2007 26 6816 6828 10.1038/sj.onc.1210764 17934488 · DOI · Paper page
  58. [61]Charles JF Inflammatory arthritis increases mouse osteoclast precursors with myeloid suppressor function J. Clin. Investig. 2012 122 4592 4605 10.1172/JCI60920 23114597 PMC3533532 · DOI
  59. [62]Zhou X Differentiation and persistence of memory CD8(+) T cells depend on T cell factor 1 Immunity 2010 33 229 240 10.1016/j.immuni.2010.08.002 20727791 PMC2928475 · DOI
  60. [63]Ota Y Generation mechanism of RANKL(+) effector memory B cells: relevance to the pathogenesis of rheumatoid arthritis Arthritis Res. Ther. 2016 18 67 10.1186/s13075-016-0957-6 26980135 PMC4793760 · DOI
  61. [64]Forster R Davalos-Misslitz AC Rot A CCR7 and its ligands: balancing immunity and tolerance Nat. Rev. Immunol. 2008 8 362 371 10.1038/nri2297 18379575 · DOI · Paper page
  62. [65]Di Rosa F Gebhardt T Bone marrow T cells and the integrated functions of recirculating and tissue-resident memory T cells Front. Immunol. 2016 7 51 26909081 PMC4754413
  63. [67]Sato N MyD88 but not TRIF is essential for osteoclastogenesis induced by lipopolysaccharide, diacyl lipopeptide, and IL-1alpha J. Exp. Med. 2004 200 601 611 10.1084/jem.20040689 15353553 PMC2212746 · DOI
  64. [68]Guss JD Alterations to the gut microbiome impair bone strength and tissue material properties J. Bone Miner. Res. 2017 32 1343 1353 10.1002/jbmr.3114 28244143 PMC5466506 · DOI
  65. [69]Yokota K Combination of tumor necrosis factor alpha and interleukin-6 induces mouse osteoclast-like cells with bone resorption activity both in vitro and in vivo Arthritis Rheumatol. 2014 66 121 129 10.1002/art.38218 24431283 · DOI
  66. [70]Ruscitti P The role of IL-1beta in the bone loss during rheumatic diseases Mediators Inflamm. 2015 2015 782382 10.1155/2015/782382 25954061 PMC4410538 · DOI
  67. [71]Tilstra JS B cell-intrinsic TLR9 expression is protective in murine lupus J. Clin. Investig. 2020 130 3172 3187 10.1172/JCI132328 32191633 PMC7260024 · DOI
  68. [72]Al Sayed MF T-cell-secreted TNFalpha induces emergency myelopoiesis and myeloid-derived suppressor cell differentiation in cancer Cancer Res. 2019 79 346 359 10.1158/0008-5472.CAN-17-3026 30389698 · DOI
  69. [73]Ko CY Chang WC Wang JM Biological roles of CCAAT/Enhancer-binding protein delta during inflammation J. Biomed. Sci. 2015 22 6 10.1186/s12929-014-0110-2 25591788 PMC4318212 · DOI
  70. [74]Kaufmann E BCG educates hematopoietic stem cells to generate protective innate immunity against tuberculosis Cell 2018 172 176 190 e119 10.1016/j.cell.2017.12.031 29328912 · DOI · Paper page
  71. [76]Yamamoto R Clonal analysis unveils self-renewing lineage-restricted progenitors generated directly from hematopoietic stem cells Cell 2013 154 1112 1126 10.1016/j.cell.2013.08.007 23993099 · DOI
  72. [77]Chen L Ozato K Innate immune memory in hematopoietic stem/progenitor cells: myeloid-biased differentiation and the role of interferon Front. Immunol. 2021 12 621333 10.3389/fimmu.2021.621333 33854500 PMC8039377 · DOI
  73. [78]Jack GD Zhang L Friedman AD M-CSF elevates c-Fos and phospho-C/EBPalpha(S21) via ERK whereas G-CSF stimulates SHP2 phosphorylation in marrow progenitors to contribute to myeloid lineage specification Blood 2009 114 2172 2180 10.1182/blood-2008-11-191536 19587381 PMC2744575 · DOI
  74. [79]Satoh Y The Satb1 protein directs hematopoietic stem cell differentiation toward lymphoid lineages Immunity 2013 38 1105 1115 10.1016/j.immuni.2013.05.014 23791645 PMC3777575 · DOI
  75. [83]Duan H Li Z Mazzone T Tumor necrosis factor-alpha modulates monocyte/macrophage apoprotein E gene expression J. Clin. Investig. 1995 96 915 922 10.1172/JCI118139 7635986 PMC185279 · DOI
  76. [84]Grigoriadis AE c-Fos: a key regulator of osteoclast-macrophage lineage determination and bone remodeling Science 1994 266 443 448 10.1126/science.7939685 7939685 · DOI
  77. [85]Tong X Overexpression of c-Fos reverses osteoprotegerin-mediated suppression of osteoclastogenesis by increasing the Beclin1-induced autophagy J. Cell. Mol. Med 2020 25 937 945 10.1111/jcmm.16152 33277741 PMC7812271 · DOI
  78. [87]Elinav E NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis Cell 2011 145 745 757 10.1016/j.cell.2011.04.022 21565393 PMC3140910 · DOI · Paper page
  79. [88]Thevaranjan N Age-associated microbial dysbiosis promotes intestinal permeability, systemic inflammation, and macrophage dysfunction Cell Host Microbe 2017 21 455 466 e454 10.1016/j.chom.2017.03.002 28407483 PMC5392495 · DOI · Paper page
  80. [89]Round JL Mazmanian SK The gut microbiota shapes intestinal immune responses during health and disease Nat. Rev. Immunol. 2009 9 313 323 10.1038/nri2515 19343057 PMC4095778 · DOI · Paper page
  81. [90]Lima CA Lyra AC Rocha R Santana GO Risk factors for osteoporosis in inflammatory bowel disease patients World J. Gastrointest. Pathophysiol. 2015 6 210 218 10.4291/wjgp.v6.i4.210 26600979 PMC4644885 · DOI
  82. [91]McFarlane L Truong V Palmer JS Wilhelm D Novel PCR assay for determining the genetic sex of mice Sex. Dev. 2013 7 207 211 10.1159/000348677 23571295 · DOI
  83. [93]Efremova M Vento-Tormo M Teichmann SA Vento-Tormo R CellPhoneDB: inferring cell-cell communication from combined expression of multi-subunit ligand-receptor complexes Nat. Protoc. 2020 15 1484 1506 10.1038/s41596-020-0292-x 32103204 · DOI · Paper page

Cited by

Sorted by citations

Authors
Ding, P., Tan, Q., Wei, Z., Chen, Q., Wang, C., Qi, L., Wen, L., Zhang, C., & Yao, C.
Affiliations
  • Shanghai Jiao Tong University (CN)
  • Second Affiliated Hospital of Soochow University (CN)
Corresponding author
Zhang, Changqing
Venue
Bone Research
Published
2022-05-27
Volume
10
Issue
1
Pages
42-42
ISSN
  • 2095-4700 (ISSN-L)
  • 2095-6231
OpenAlex
W4281741064
Cited by
47
References
11
Citations by year
2026: 9 · 2025: 13 · 2024: 12 · 2023: 9 · 2022: 4
FWCI
3.10
Type
journal article
Language
en
Open access
Locations
  • Bone Research (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Funders
  • Natural Science Foundation of Shanghai (21ZR1448600, 2018YFC1106300, 81820100820)
  • National Natural Science Foundation of China (81820100820, 81400855, 81372845)
  • Science and Technology Commission of Shanghai Municipality (14pj1407200)
  • National Institutes of Health (4r01dk092882-05)
  • National Institute of Diabetes and Digestive and Kidney Diseases (R01-DK-092882, R01DK126809, P30DK045735, R01DK130318)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
  • Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
  • Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
Keywords
TLR9, osteoclastogenesis, bone loss, gut microbiota, dysbiosis, myelopoiesis, hematopoietic stem cells, CD4+ T cells, RANKL, TNF-α, IL-1β, bone remodeling, bone metabolism

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review